Back to search

Article

The Translocator Protein (TSPO) Genetic Polymorphism A147T is Associated with Worse Survival in Male Glioblastoma Patients

2021-08-05

Abstract excerpt

Glioblastoma (GBM) is the most common primary brain tumor in adults, with few available therapies and a 5-year survival rate of 7.2%. Hence, strategies for improving GBM prognosis are urgently needed. The translocator protein 18kDa (TSPO) plays crucial roles in essential mito-chondria-based physiological processes and is a validated biomarker of neuroinflammation, which is implicated in GBM progression. The TSPO g...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
417c8082-0517-5937-adc7-636b07ab582a
DOI
10.20944/preprints202108.0135.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Translocator Protein (TSPO) Genetic Polymorphism A147T is Associated with Worse Survival in Male Glioblastoma PatientsDOI 10.20944/preprints202108.0135.v1
Select a neighboring publication to make it the new centre.